BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31345230)

  • 1. EGF-activated PI3K/Akt signalling coordinates leucine uptake by regulating LAT3 expression in prostate cancer.
    Zhang BK; Moran AM; Bailey CG; Rasko JEJ; Holst J; Wang Q
    Cell Commun Signal; 2019 Jul; 17(1):83. PubMed ID: 31345230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development.
    Wang Q; Tiffen J; Bailey CG; Lehman ML; Ritchie W; Fazli L; Metierre C; Feng YJ; Li E; Gleave M; Buchanan G; Nelson CC; Rasko JE; Holst J
    J Natl Cancer Inst; 2013 Oct; 105(19):1463-73. PubMed ID: 24052624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression.
    Wang Q; Bailey CG; Ng C; Tiffen J; Thoeng A; Minhas V; Lehman ML; Hendy SC; Buchanan G; Nelson CC; Rasko JE; Holst J
    Cancer Res; 2011 Dec; 71(24):7525-36. PubMed ID: 22007000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of LAT3 in prostate cancer: Its downstream target and relationship with androgen receptor.
    Rii J; Sakamoto S; Sugiura M; Kanesaka M; Fujimoto A; Yamada Y; Maimaiti M; Ando K; Wakai K; Xu M; Imamura Y; Shindo N; Hirota T; Kaneda A; Kanai Y; Ikehara Y; Anzai N; Ichikawa T
    Cancer Sci; 2021 Sep; 112(9):3871-3883. PubMed ID: 34050700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoterpene glycoside ESK246 from Pittosporum targets LAT3 amino acid transport and prostate cancer cell growth.
    Wang Q; Grkovic T; Font J; Bonham S; Pouwer RH; Bailey CG; Moran AM; Ryan RM; Rasko JE; Jormakka M; Quinn RJ; Holst J
    ACS Chem Biol; 2014 Jun; 9(6):1369-76. PubMed ID: 24762008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR signaling pathway negatively regulates PSA expression and secretion via the PI3K-Akt pathway in LNCaP prostate cancer cells.
    Hakariya T; Shida Y; Sakai H; Kanetake H; Igawa T
    Biochem Biophys Res Commun; 2006 Mar; 342(1):92-100. PubMed ID: 16472761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mTORC1/4E-BP pathway coordinates hemoglobin production with L-leucine availability.
    Chung J; Bauer DE; Ghamari A; Nizzi CP; Deck KM; Kingsley PD; Yien YY; Huston NC; Chen C; Schultz IJ; Dalton AJ; Wittig JG; Palis J; Orkin SH; Lodish HF; Eisenstein RS; Cantor AB; Paw BH
    Sci Signal; 2015 Apr; 8(372):ra34. PubMed ID: 25872869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport.
    Peyrollier K; Hajduch E; Blair AS; Hyde R; Hundal HS
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):361-8. PubMed ID: 10947949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
    Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S
    Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways.
    Qiu Q; Yang M; Tsang BK; Gruslin A
    Reproduction; 2004 Sep; 128(3):355-63. PubMed ID: 15333786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The involvement of the docking protein Gab1 in mitogenic signalling induced by EGF and HGF in rat hepatocytes.
    Aasrum M; Ødegård J; Sandnes D; Christoffersen T
    Biochim Biophys Acta; 2013 Dec; 1833(12):3286-3294. PubMed ID: 24126105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
    Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.
    Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q
    Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.
    Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H
    Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters.
    Babu E; Kanai Y; Chairoungdua A; Kim DK; Iribe Y; Tangtrongsup S; Jutabha P; Li Y; Ahmed N; Sakamoto S; Anzai N; Nagamori S; Endou H
    J Biol Chem; 2003 Oct; 278(44):43838-45. PubMed ID: 12930836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGF promotes neuroendocrine-like differentiation of prostate cancer cells in the presence of LY294002 through increased ErbB2 expression independent of the phosphatidylinositol 3-kinase-AKT pathway.
    Cortés MA; Cariaga-Martinez AE; Lobo MV; Martín Orozco RM; Motiño O; Rodríguez-Ubreva FJ; Angulo J; López-Ruiz P; Colás B
    Carcinogenesis; 2012 Jun; 33(6):1169-77. PubMed ID: 22461520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DRAM1 regulates autophagy and cell proliferation via inhibition of the phosphoinositide 3-kinase-Akt-mTOR-ribosomal protein S6 pathway.
    Lu T; Zhu Z; Wu J; She H; Han R; Xu H; Qin ZH
    Cell Commun Signal; 2019 Mar; 17(1):28. PubMed ID: 30902093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TEIF associated centrosome activity is regulated by EGF/PI3K/Akt signaling.
    Zhao J; Zou Y; Liu H; Wang H; Zhang H; Hou W; Li X; Jia X; Zhang J; Hou L; Zhang B
    Biochim Biophys Acta; 2014 Sep; 1843(9):1851-64. PubMed ID: 24769208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of amino acid transporter LAT3 expression on proliferation of K562 cells.
    Xu SM; Tang K; Meng L; Tang Y
    J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):632-635. PubMed ID: 24142711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein.
    Hong SY; Yu FX; Luo Y; Hagen T
    Cell Signal; 2016 May; 28(5):377-383. PubMed ID: 26826652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.